Modeling and simulation at the interface of nonclinical and early clinical drug development
- PMID: 23835941
- PMCID: PMC3600756
- DOI: 10.1038/psp.2013.3
Modeling and simulation at the interface of nonclinical and early clinical drug development
References
-
- Gabrielsson J., Dolgos H., Gillberg P.G., Bredberg U., Benthem B., &, Duker G. Early integration of pharmacokinetic and dynamic reasoning is essential for optimal development of lead compounds: strategic considerations. Drug Discov. Today. 2009;14:358–372. - PubMed
-
- Danhof M., de Jongh J., De Lange E.C., Della Pasqua O., Ploeger B.A., &, Voskuyl R.A. Mechanism-based pharmacokinetic-pharmacodynamic modeling: biophase distribution, receptor theory, and dynamical systems analysis. Annu. Rev. Pharmacol. Toxicol. 2007;47:357–400. - PubMed
-
- Sorger P.K.et al. Quantitative and systems pharmacology in the post-genomic era: new approaches to discovering drugs and understanding therapeutic mechanisms NIHWhite Paper by the QSP Workshop Group (2011
LinkOut - more resources
Full Text Sources
Other Literature Sources
